| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0902916.6 | 2009-02-20 | ||
| GBGB0902916.6AGB0902916D0 (en) | 2009-02-20 | 2009-02-20 | Antibody therapy |
| Publication Number | Publication Date |
|---|---|
| WO2010094981A2 WO2010094981A2 (en) | 2010-08-26 |
| WO2010094981A3true WO2010094981A3 (en) | 2010-12-23 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/GB2010/050304WO2010094981A2 (en) | 2009-02-20 | 2010-02-22 | Antibody therapy |
| Country | Link |
|---|---|
| GB (1) | GB0902916D0 (en) |
| WO (1) | WO2010094981A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013063395A1 (en) | 2011-10-27 | 2013-05-02 | Nkt Therapeutics Inc. | Humanized antibodies to inkt |
| CN114989297B (en)* | 2022-06-14 | 2022-10-25 | 北京科跃中楷生物技术有限公司 | Kit comprising horseradish peroxidase-labeled antibody |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006109045A2 (en)* | 2005-04-09 | 2006-10-19 | Fusion Antibodies Limited | Cathepsin s antibody |
| WO2008044076A2 (en)* | 2006-10-12 | 2008-04-17 | Fusion Antibodies Limited | Therapy targeting cathepsin s |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5283187A (en) | 1987-11-17 | 1994-02-01 | Brown University Research Foundation | Cell culture-containing tubular capsule produced by co-extrusion |
| US4892538A (en) | 1987-11-17 | 1990-01-09 | Brown University Research Foundation | In vivo delivery of neurotransmitters by implanted, encapsulated cells |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3920358A1 (en) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | BISPECIFIC AND OLIGO-SPECIFIC, MONO- AND OLIGOVALENT ANTI-BODY CONSTRUCTS, THEIR PRODUCTION AND USE |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| DE69233482T2 (en) | 1991-05-17 | 2006-01-12 | Merck & Co., Inc. | Method for reducing the immunogenicity of antibody variable domains |
| ES2136092T3 (en) | 1991-09-23 | 1999-11-16 | Medical Res Council | PROCEDURES FOR THE PRODUCTION OF HUMANIZED ANTIBODIES. |
| JPH07501451A (en) | 1991-11-25 | 1995-02-16 | エンゾン・インコーポレイテッド | Multivalent antigen binding protein |
| AU4528493A (en) | 1992-06-04 | 1994-01-04 | Regents Of The University Of California, The | In vivo gene therapy with intron-free sequence of interest |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006109045A2 (en)* | 2005-04-09 | 2006-10-19 | Fusion Antibodies Limited | Cathepsin s antibody |
| WO2008044076A2 (en)* | 2006-10-12 | 2008-04-17 | Fusion Antibodies Limited | Therapy targeting cathepsin s |
| Title |
|---|
| BURDEN ROBERTA E ET AL: "Antibody-Mediated Inhibition of Cathepsin S Blocks Colorectal Tumor Invasion and Angiogenesis", CLINICAL CANCER RESEARCH, vol. 15, no. 19, October 2009 (2009-10-01), pages 6042 - 6051, XP002583183, ISSN: 1078-0432* |
| MACCALLUM R M ET AL: "Antibody-antigen interactions: Contact analysis and binding site topography", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1006/JMBI.1996.0548, vol. 262, no. 5, 1 January 1996 (1996-01-01), pages 732 - 745, XP002242391, ISSN: 0022-2836* |
| RUDIKOFF S ET AL: "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US LNKD- DOI:10.1073/PNAS.79.6.1979, vol. 79, 1 March 1982 (1982-03-01), pages 1979 - 1983, XP007901436, ISSN: 0027-8424* |
| TOL JOLIEN ET AL: "Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer", NEW ENGLAND JOURNAL OF MEDICINE, THE, MASSACHUSETTS MEDICAL SOCIETY, WALTHAM, MA, US LNKD- DOI:10.1056/NEJMOA0808268, vol. 360, no. 6, 1 February 2009 (2009-02-01), pages 563 - 572, XP002526064, ISSN: 0028-4793* |
| VAJDOS F F ET AL: "Comprehensive Functional Maps of the Antigen-binding Site of an Anti-ErbB2 Antibody Obtained with Shotgun Scanning Mutagenesis", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1016/S0022-2836(02)00264-4, vol. 320, no. 2, 5 July 2002 (2002-07-05), pages 415 - 428, XP004449739, ISSN: 0022-2836* |
| WU HERREN ET AL: "Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues", JOURNAL OF MOLECULAR BIOLOGY,, vol. 294, no. 1, 19 November 1999 (1999-11-19), pages 151 - 162, XP002582261* |
| Publication number | Publication date |
|---|---|
| WO2010094981A2 (en) | 2010-08-26 |
| GB0902916D0 (en) | 2009-04-08 |
| Publication | Publication Date | Title |
|---|---|---|
| WO2007115049A3 (en) | Humanized monoclonal antibodies to hepatocyte growth factor | |
| WO2011143624A3 (en) | Humanized and chimeric monoclonal antibodies to cd47 | |
| WO2011003557A8 (en) | A complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agent | |
| WO2011110642A3 (en) | Monoclonal antibodies against c-met | |
| WO2013072813A3 (en) | Cytotoxic peptides and antibody drug conjugates thereof | |
| WO2011147982A3 (en) | Monoclonal antibodies against her2 epitope | |
| WO2010066803A3 (en) | Human antibodies against human tissue factor | |
| EP4434550A3 (en) | Human antibody drug conjugates against tissue culture | |
| WO2011160119A8 (en) | Anti-gd2 antibodies | |
| WO2010054265A3 (en) | Monoclonal antibodies to fibroblast growth factor receptor 2 | |
| WO2009083009A3 (en) | Monoclonal antibodies against cd32b | |
| WO2012149356A3 (en) | Anti-cd40 antibodies and methods of use | |
| IL212633A (en) | Monoclonal antibody or antigen-binding fragment thereof, pharmaceutical compositions comprising the same and use thereof for the manufacture of medicaments for the treatment of cancer | |
| EP3539988A3 (en) | Monoclonal antibodies against her2 | |
| WO2007033230A3 (en) | Anti-cd3 antibody formulations | |
| WO2008100805A3 (en) | Anti-robo4 antibodies and uses therefor | |
| WO2012064792A3 (en) | Protein complexes for antigen binding and methods of use | |
| JOP20210044A1 (en) | Anti-CD38 . antibody | |
| WO2008121615A3 (en) | Antibody formulation | |
| AU2009301431A8 (en) | Bispecific anti-VEGF/anti-ANG-2 antibodies | |
| WO2012019165A3 (en) | Methods of inhibition of protein fucosylation in vivo using fucose analogs | |
| WO2012177595A9 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
| EA201290849A1 (en) | OPTIMIZED MONOCLONAL ANTIBODIES AGAINST THE TISSUE FACTOR INHIBITOR (TFPI) | |
| WO2008027739A3 (en) | Antibodies to ntb-a | |
| WO2010132370A3 (en) | Soluble tlt-1 for the treatment and diagnosis of sepsis |
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | Ref document number:10706043 Country of ref document:EP Kind code of ref document:A2 | |
| NENP | Non-entry into the national phase | Ref country code:DE | |
| 122 | Ep: pct application non-entry in european phase | Ref document number:10706043 Country of ref document:EP Kind code of ref document:A2 |